Virtus LifeSci Biotech Products ETF
13 hedge funds and large institutions have $7.72M invested in Virtus LifeSci Biotech Products ETF in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.66M | |
| 2 | +$1.08M | |
| 3 | +$431K | |
| 4 |
Morgan Stanley
New York
|
+$358K |
| 5 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
|
+$303K |
Top Sellers
| 1 | -$469K | |
| 2 | -$429K | |
| 3 | -$296K | |
| 4 |
JCM
Jag Capital Management
St Louis,
Missouri
|
-$212K |
| 5 |
CAMG
CWA Asset Management Group
Naples,
Florida
|
-$105K |
